Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
批准号:
9354824
负责人:
Victor Lobanenkov
金额:
$60.77万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAffectAreaBindingBinding SitesBiological AssayBrothersCancer cell lineCell LineCellsChIP-seqChromatinDNA BindingDNA Binding DomainDNA SequenceDerivation procedureDevelopmentDiagnosticDiseaseES Cell LineEctopic ExpressionEpigenetic ProcessEvolutionGametogenesisGene DuplicationGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGerm CellsGoalsHumanHuman GenomeImmunological DiagnosisIn VitroK562 CellsKnock-outMCF7 cellMaintenanceMalignant NeoplasmsMapsMediatingMeiosisMitoticMolecularMonoclonal AntibodiesMusPathologicPatternPlasmidsPlayProteinsProtocols documentationRattusRegulationRegulatory ElementReporterRepressionRoleSiteStem cellsStructureTATA-Box Binding ProteinTechnologyTranscriptTranscriptional ActivationTransfectionTranslational ResearchVaccinationbasec-ets1 transcription factorcancer cellcancer immunotherapycancer testis antigencancer therapyclinical applicationembryonic stem cellepigenetic regulationgenome-wideimprintimprovedin vivomalignant breast neoplasmmelanoma-associated antigen-A1mouse genomeneuronal cell bodynoveloverexpressionparalogous genepluripotencypolyclonal antibodyprogramspromoterprotein protein interactionresearch studytreatment sitezinc finger nuclease
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BORIS (Brother Of the Regulator of Imprinting Sites) emerged during early evolution of amniotes as the result of CTCF gene duplication. CTCF and BORIS encode proteins that share an almost identical DNA binding domain recognizing the same DNA sequences in vivo and in vitro. It has long been thought that CTCF and BORIS possess distinct functions and act in a mutually exclusive manner. Indeed, while CTCF is ubiquitously expressed, BORIS expression is strictly restricted to germ cells in normal development. However, BORIS is aberrantly expressed in a wide range of cancers, and its function in that context has not been characterized. To address this problem, we have developed and utilized a set of monoclonal and polyclonal antibodies to map CTCF and BORIS binding sites in both human and mouse genomes. ChIP-seq analysis of several BORIS-expressing human cancer cell lines and mouse germ cells established that the pattern of BORIS binding is similar across cell lines of independent origin, recapitulates BORIS binding in germ cells, and thus reflects an underlying encoding of the binding regions for their propensity to bind BORIS. We uncovered that this encoding largely reflects the ability of these regions to be co-bound by CTCF and BORIS heterodimers or by BORIS or CTCF homodimers. Those regions represent the so-called dual "2xCTS" sites capable of binding both factors to at least two adjacent 11ZF-recognized motifs placed in close cis proximity near each other, and mutually reinforced by their cooperative protein-protein interactions. We found that the cooperation of CTCF and BORIS at 2xCTSes is critical for the transcriptional program of cancer and germ cells. Depletion of BORIS gene leads to altered transcription of a large number of genes and aberrant differentiation of K562 cells, while the ectopic expression of BORIS leads to stem cell specific changes in transcription of MCF7 cells. In the next study, we analyzed the interplay of BORIS and the transcription factors Ets-1 and Sp1 in the regulation of MAGE-A1 gene expression. We found that ectopically expressed BORIS could activate and demethylate both the endogenous and methylated reporter MAGE-A1 promoter in MCF-7 cells and in the micrometastatic BCM1 cancer cell lines. Overexpression of Ets-1 could not further upregulate the promoter activity mediated by BORIS. Surprisingly, in co-transfection experiments we observed that Sp1 partly repressed the BORIS-mediated stimulation, while addition of an Ets-1 expression plasmid abrogated the Sp1 mediated repression of the MAGE-A1 promoter. Both BORIS and Sp1 interacted with the TATA binding protein (hTBP) suggesting the possibility of a competitive mechanism of action between BORIS and Sp1 transcript levels in reporter assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
-
批准号:10272128
-
项目类别:
-
资助金额:$85.59万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
-
批准号:10692106
-
项目类别:
-
资助金额:$71.98万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Deciphering CTCF code in mammalian host and viral epigenomes
-
批准号:10927769
-
项目类别:
-
资助金额:$164.75万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
-
批准号:10927815
-
项目类别:
-
资助金额:$70.61万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:8336243
-
项目类别:
-
资助金额:$86.88万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:8946422
-
项目类别:
-
资助金额:$68.58万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:8745378
-
项目类别:
-
资助金额:$76.58万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:8745467
-
项目类别:
-
资助金额:$76.58万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:7964430
-
项目类别:
-
资助金额:$57.84万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:7964638
-
项目类别:
-
资助金额:$59.08万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:8336142
-
项目类别:
-
资助金额:$86.88万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:8156922
-
项目类别:
-
资助金额:$73.5万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Deciphering novel binary CTCF code encrypted in Host and Proviral Epigenomes by Distinct Classes of CTCF & BORIS Binding Sites
-
批准号:9563880
-
项目类别:
-
资助金额:$64.39万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Deciphering CTCF code in mammalian host and viral epigenomes
-
批准号:10272077
-
项目类别:
-
资助金额:$85.59万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:7592372
-
项目类别:
-
资助金额:$80.49万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
-
批准号:10014136
-
项目类别:
-
资助金额:$81.94万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:9354758
-
项目类别:
-
资助金额:$60.77万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:8555944
-
项目类别:
-
资助金额:$73.55万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets
-
批准号:9161525
-
项目类别:
-
资助金额:$73.83万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
-
批准号:7732671
-
项目类别:
-
资助金额:$74.43万
-
财政年份:--
-
负责人:Victor Lobanenkov
-
依托单位:
海外基金